Artery Research

Volume 1, Issue 1, June 2007, Pages 13 - 19

Reducing arterial stiffness and wave reflection – Quest for the Holy Grail?

Authors
Azra Mahmud*
Department of Pharmacology and Therapeutics, Trinity College Dublin & Hypertension Clinic, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland

First presented at Artery 6, Athens, Greece, 22–23 September 2006

*Tel.: +353 1 8962667; fax: +353 1 4539033. E-mail address: mahmuda@tcd.ie
Corresponding Author
Azra Mahmud
Available Online 6 June 2007.
DOI
10.1016/j.artres.2007.03.001How to use a DOI?
Keywords
Arterial stiffness; Wave reflection; Pulse wave velocity; Augmentation index; Anti-hypertensive drugs; Vasodilators
Abstract

Arterial stiffness and wave reflection are fast emerging as therapeutic targets in their own right. While thiazide diuretics have little or no effect on either arterial stiffness or wave reflection, vasodilators including nitrates and phosphodiesterase type-5 inhibitors e.g., sildenafil, reduce wave reflections and aortic pressures but not aortic stiffness. β-blockers have the opposite effect; they reduce aortic stiffness but increase aortic pulse pressure and wave reflections while calcium antagonists and α-blockers show varying effects on the vascular wall. Drugs targeting the renin–angiotensin–aldosterone system, namely angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARBs) and aldosterone antagonists have been shown as the most effective in reducing both arterial stiffness and wave reflection, and in some cases, to a greater extent than predicted from the extent of blood pressure (BP) reduction. Also, there is evidence of an additive effect on arterial stiffness with combined ACEI and ARBs. Exploring further the synergistic effects of anti-hypertensive drugs on arterial stiffness, a polypill containing a low-dose combination of a thiazide diuretic, calcium antagonist, β-blocker and an ACEI, decreased arterial stiffness more than the individual drugs in standard doses. However, beyond the dynamic effects of anti-hypertensive drugs, future therapies may directly target vascular structural alterations including collagen degradation, advanced glycation end-products, the matrix-metalloproteinases and vascular inflammation. Finally, one can speculate about the role of pharmacogenomics which may help tailor ‘de-stiffening therapy’ in individuals with stiff arteries.

Copyright
© 2007 Published by Elsevier B.V. on behalf of Association for Research into Arterial Structure and Physiology.
Open Access
This is an open access article distributed under the CC BY-NC license.

Download article (PDF)
View full text (HTML)

Journal
Artery Research
Volume-Issue
1 - 1
Pages
13 - 19
Publication Date
2007/06/06
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2007.03.001How to use a DOI?
Copyright
© 2007 Published by Elsevier B.V. on behalf of Association for Research into Arterial Structure and Physiology.
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

TY  - JOUR
AU  - Azra Mahmud
PY  - 2007
DA  - 2007/06/06
TI  - Reducing arterial stiffness and wave reflection – Quest for the Holy Grail?
JO  - Artery Research
SP  - 13
EP  - 19
VL  - 1
IS  - 1
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2007.03.001
DO  - 10.1016/j.artres.2007.03.001
ID  - Mahmud2007
ER  -